Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial folate synthesis pathway is a metabolic route enabling bacteria to produce folate and its derivatives, essential cofactors for one-carbon transfer reactions vital for DNA, RNA, and amino acid synthesis. It begins with GTP, pABA, and glutamate as precursors. Key enzymes include guanine cyclohydrolase I (GCYH I), dihydroneopterin hydrolase, dihydroneopterin aldolase, hydroxymethyl-dihydropteridine pyrophosphokinase (HPPK), dihydropteroate synthase (DHPS), dihydrofolate synthase, and dihydrofolate reductase (DHFR). The pathway is a validated target for antimicrobial drugs because mammals cannot synthesize folate, making it a selective vulnerability in bacteria.
Sulfonamides inhibit dihydropteroate synthase (DHPS). Trimethoprim inhibits dihydrofolate reductase (DHFR). Both block folate synthesis, inhibiting bacterial growth.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Folate Synthesis Pathway (Bacteria) (N/A).